Prempro is a drug owned by Wyeth Pharmaceuticals Llc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jan 17, 2015. Details of Prempro's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5547948 | Controlled release of steroids from sugar coatings |
Jan, 2015
(9 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Prempro is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Prempro's family patents as well as insights into ongoing legal events on those patents.
Prempro's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Prempro's generic launch date based on the expiry of its last outstanding patent is estimated to be Jan 17, 2015 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Prempro Generics:
There are no approved generic versions for Prempro as of now.
Alternative Brands for Prempro
There are several other brand drugs using the same active ingredient (Estrogens, Conjugated; Medroxyprogesterone Acetate) as Prempro. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| Wyeth Pharms |
|
About Prempro
Prempro is a drug owned by Wyeth Pharmaceuticals Llc. Prempro uses Estrogens, Conjugated; Medroxyprogesterone Acetate as an active ingredient. Prempro was launched by Wyeth Pharms in 1995.
Approval Date:
Prempro was approved by FDA for market use on 17 November, 1995.
Active Ingredient:
Prempro uses Estrogens, Conjugated; Medroxyprogesterone Acetate as the active ingredient. Check out other Drugs and Companies using Estrogens, Conjugated; Medroxyprogesterone Acetate ingredient
Dosage:
Prempro is available in tablet form for oral-28 use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 0.625MG;5MG | TABLET | Prescription | ORAL-28 |
| 0.45MG;1.5MG | TABLET | Prescription | ORAL-28 |
| 0.3MG;1.5MG | TABLET | Prescription | ORAL-28 |
| 0.625MG;2.5MG | TABLET | Prescription | ORAL-28 |